Evidence map›Paper›PMID 38195602›Full record

ArticleNature communications2024

Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma.

Andrew R Hamel, Wenjun Yan, John M Rouhana, Aboozar Monovarfeshani, Xinyi Jiang, Puja A Mehta, Jayshree Advani, Yuyang Luo, Qingnan Liang, Skanda Rajasundaram and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
28.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension.medRxiv : the preprint server for health sciences · 2026
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 12 countries.

Andrew R HamelOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0001-6420-9573
Wenjun Yan *Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA, USA.ORCID 0000-0003-3568-4265
John M Rouhana *Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.
Aboozar Monovarfeshani *Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA, USA.
Xinyi JiangMRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-3966-6355
Puja A MehtaOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0003-3205-1163
Jayshree AdvaniNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MA, USA.
Yuyang LuoOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.
Qingnan LiangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-2030-1949
Skanda RajasundaramDepartment of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Arushi ShrivastavaOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0002-2460-4875
Katherine DuchinskiOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0003-0025-373X
Sreekar MantenaOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0002-8834-1461
Jiali WangOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0002-4459-9284
Tavé van ZylDepartment of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA, USA.
Louis R PasqualeDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anand SwaroopNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MA, USA.ORCID 0000-0002-1975-1141
Puya GharahkhaniQIMR Berghofer Medical Research Institute, Brisbane, QLD, 4029, Australia.ORCID 0000-0002-4203-5952
Anthony P KhawajaNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.ORCID 0000-0001-6802-8585
Stuart MacGregorQIMR Berghofer Medical Research Institute, Brisbane, QLD, 4029, Australia.ORCID 0000-0001-6731-8142
International Glaucoma Genetics Consortium (IGGC)
Rui ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-4387-9735
Veronique VitartMRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-4991-3797
Joshua R SanesDepartment of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA, USA.ORCID 0000-0001-8926-8836
Janey L WiggsOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0003-1890-3278
Ayellet V SegrèOcular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA. ayellet_segre@meei.harvard.edu.ORCID 0000-0001-6806-5845
Broad Institute · USErasmus MC · NLHarvard University · USdeCODE Genetics (Iceland) · ISInstitute of Genetics and Cancer · GBMoorfields Eye Hospital NHS Foundation Trust · GBBaylor College of Medicine · USChinese University of Hong Kong · HKGenome Institute of Singapore · SGKing's College London · GBNational Institutes of Health · USNational University of Singapore · SGQIMR Berghofer Medical Research Institute · AUSingapore National Eye Center · SGUniversity of Iceland · ISUniversity of Tasmania · AUUniversity of Wisconsin–Madison · USBeijing Tongren Hospital · CNCarver Bible College · USEdinburgh Cancer Research · GB

Funding

Mechanisms, modeling and therapies of retinal and macular neurodegenerationZIAEY000546 · NEI · NATIONAL EYE INSTITUTE · PI SWAROOP, ANAND · 2015 to 2025
$36.3M
Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Eric A Pierce · 2002 to 2026
$15.1M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
The NEIGHBORHOOD: POAG Heritable Overall Operational DatabaseR01EY022305 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI WIGGS, JANEY L · 2012 to 2025
$7.9M
Uncovering novel biological processes and pathogenic mechanisms for glaucomaR01EY031424 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Ayellet Vered Segre · 2020 to 2026
$4.5M
Understanding the clinical impact of cumulative genetic risk to glaucomaR01EY032559 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Louis Robert Pasquale, Janey L Wiggs · 2021 to 2026
$4.3M
Intramural NIH HHS ZIA EY000546Medical Research Council MC_UU_00007/10Medical Research Council MC_UU_00035/15Medical Research Council MR/T040912/1NEI NIH HHS P30 EY014104NEI NIH HHS R01 EY022305NEI NIH HHS R01 EY031424NEI NIH HHS R01 EY032559NHGRI NIH HHS T32 HG002295NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

Primary open-angle glaucoma (POAG), characterized by retinal ganglion cell death, is a leading cause of irreversible blindness worldwide. However, its molecular and cellular causes are not well understood. Elevated intraocular pressure (IOP) is a major risk factor, but many patients have normal IOP. Colocalization and Mendelian randomization analysis of >240 POAG and IOP genome-wide association study (GWAS) loci and overlapping expression and splicing quantitative trait loci (e/sQTLs) in 49 GTEx tissues and retina prioritizes causal genes for 60% of loci. These genes are enriched in pathways implicated in extracellular matrix organization, cell adhesion, and vascular development. Analysis of single-nucleus RNA-seq of glaucoma-relevant eye tissues reveals that the POAG and IOP colocalizing genes and genome-wide associations are enriched in specific cell types in the aqueous outflow pathways, retina, optic nerve head, peripapillary sclera, and choroid. This study nominates IOP-dependent and independent regulatory mechanisms, genes, and cell types that may contribute to POAG pathogenesis.

Indexed as

GlaucomaGlaucoma, Open-AngleCausalityGene Expression RegulationGenome-Wide Association StudyHumans

Identifiers

PMID38195602
PMCPMC10776627
OpenAlexW4390773218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.